-

Huami Appoints Brad Samson as Vice President Investor Relations

CUPERTINO, Calif.--(BUSINESS WIRE)--Huami Corp. and Huami-USA (NYSE: HMI), whose mission is to connect health with technology, today announced that Brad Samson has joined the company as vice president investor relations.

Samson brings extensive experience in investor relations, healthcare, wellness and technology. He previously led investor relations at five companies ranging from small caps to Silicon Valley unicorns.

“Huami is one of the global players in health and fitness data, analytics and wearables, but the company is not well-known to U.S. investors,” said Samson. “Huami’s 42.3 million units shipped in 2019 represented 26% of global smart watch and fitness band shipments last year1; with proprietary technology in the space as evidenced by the June 15 announcement of its second-generation AI chip, the Huangshan-2; and achieving $US 835M in revenue and $US 1.28 in diluted GAAP EPADS for 2019. I look forward to introducing investors to Huami’s growth opportunities.”

"Brad’s financial acumen and deep expertise in leading investor communications in the wearable technology sector is a tremendous asset to us, especially during this unprecedented time,” said Mike Yeung, COO, Huami. Brad brings a deep understanding of the complexities of our sector and a reputation for proactive relationship-building and stakeholder communications. We’re thrilled to welcome him to the Huami family.”

About Huami Corporation (NYSE: HMI)

Huami’s mission is to connect health with technology. Since its inception in 2013, Huami has developed a platform of proprietary technology including AI chips, biometric sensors, and data algorithms, which drive a broadening line of smart health products for consumers, and analytics services for industry. In 2019, Huami shipped 42.3 million units of smart wearable devices, including its own Amazfit brand, and products developed and manufactured for Xiaomi and Timex, comprising 26% of global category shipments. Huami Corporation is based in Hefei, China, with U.S. operations, Huami-USA, based in Cupertino, Calif. For more information, please visit https://www.huami.com/investor/pages/company-profile.

1 IDC, Correcting and Replacing Shipments of Wearable Devices, 3/10/20

Contacts

For media inquiries:
lydia.huang@huami-usa.com, c: 407-800-5625

For investor inquiries:
brad.samson@huami-usa.com, c: 714-955-3951

Industry:

Huami Corporation

NYSE:HMI
Release Summary
Huami Appoints Brad Samson as Vice President Investor Relations
Release Versions
English

Contacts

For media inquiries:
lydia.huang@huami-usa.com, c: 407-800-5625

For investor inquiries:
brad.samson@huami-usa.com, c: 714-955-3951

More News From Huami Corporation

Zepp Health Moves To AWS to Power Global Expansion

CUPERTINO, Calif.--(BUSINESS WIRE)--Zepp Health Corp. (NYSE: ZEPP) today announced that it has chosen to move the vast majority of its IT infrastructure to Amazon Web Services, Inc. (AWS), an Amazon.com company. Zepp Health is leveraging AWS’s global infrastructure, industry-leading security and compliance capabilities, and comprehensive suite of cloud services to drive its business strategy in more than 70 countries and support 38 million smart wearable device users worldwide. Zepp Health deve...

Zepp Health Expands Partnership with Rouumtech to Private-Label Custom Europa™ Portable X-ray System and Full Product Line in China

CUPERTINO, Calif. & GOYANG-SI, South Korea--(BUSINESS WIRE)--Zepp Health expands partnership with Rouumtech to private-label custom Europa™ portable X-ray system and full product line in China....

Huami Corp Invests $5 Million in Hyperfine Research D Round to Support Accelerated Application of Disruptive MRI Technology

BEIJING & CUPERTINO, Calif.--(BUSINESS WIRE)--Huami Corp. (NYSE: HMI) today announced that it has invested $5 million in Hyperfine Research’s D round of funding, which closed on February 3, 2021. Huami’s mission is to connect health with technology, developing both consumer and industrial health technologies. The company believes its miniaturization engineering expertise dovetails with efforts to miniaturize medical imaging technology which can disrupt the locations, applications and costs of m...
Back to Newsroom